1. A mosaic mutation of phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) in X-linked hypophosphatemic rickets with mild bone phenotypes.
- Author
-
Asano S, Sako S, Funasaki Y, Takeshita Y, Niida Y, and Takamura T
- Subjects
- Asian People genetics, Bone and Bones diagnostic imaging, Familial Hypophosphatemic Rickets blood, Familial Hypophosphatemic Rickets therapy, Humans, Japan, Male, Middle Aged, Mosaicism, Parathyroid Hormone blood, Phenotype, Phosphates therapeutic use, Radiography, Sequence Deletion genetics, Vitamin D blood, Vitamin D therapeutic use, Bone and Bones abnormalities, Familial Hypophosphatemic Rickets genetics, Genetic Diseases, X-Linked genetics, PHEX Phosphate Regulating Neutral Endopeptidase genetics
- Abstract
X-linked hypophosphatemic rickets (XLH) is primarily characterized by renal phosphate wasting with hypophosphatemia, short stature, and bone deformity of the leg. Here we present a male case of XLH with relatively mild bone deformity caused by a mosaic mutation of the phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX). Polymerase chain reaction (PCR) direct sequencing revealed a novel in-frame deletion, NM-000444.6:c.671-685del p.Gln224-Ser228del, at exon 6 in PHEX as a mosaic pattern. This mutation was not found in any database and may result in a significant change in higher-order protein structure and function. TA cloning of the PCR product and clone sequencing estimated the mutation allele frequency at 21%. Literature review of the previously reported three cases with novel mosaic mutations in PHEX, together with the present case, suggests that the rates of the mutation allele correlate with phenotype severity to some extent. We initially treated him with nutritional vitamin D supplements and phosphate salts. However, to avoid the development of secondary/tertiary hyperparathyroidism, we had switched nutritional to active vitamin D supplementation with reduced phosphorus salts. The present report contributes to understanding the relationship between the mosaic rate, in addition to the mutation locus, of the PHEX gene, and clinical features of XLH.
- Published
- 2021
- Full Text
- View/download PDF